Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Research
[키워드] 95% CI
acute respiratory distress
Admission
age
Analysis
ARDS
benefit
Clinical effect
cohort study
collected data
competing
conducted
Corticosteroid
corticosteroid treatment
Corticosteroids
COVID-19
COVID-19-associated acute respiratory distress syndrome
COVID-19-associated ARDS
Effect
Effectiveness
hospital
ICU
ICU admission
identify
in-hospital mortality
individual
intensive care
intensive care unit
Invasive mechanical ventilation
mechanically ventilated
Mortality
multicentre
no significant difference
non-survivor
not differ
outcome
Patient
patients
patients treated
performed
propensity score matching
question
required
Research
Result
Retrospective study
risk
secondary
Secondary outcomes
sensitivity analysis
severe ARDS
severe coronavirus disease
Shock
short-term survival
Spanish
Specific
subgroup
supplementary material
survival
syndrome
Tocilizumab
Treatment
untreated patient
ventilator-free day
were excluded
[DOI] 10.1186/s13613-021-00951-0 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13613-021-00951-0 PMC 바로가기 [Article Type] Research